Old Web
English
Sign In
Acemap
>
authorDetail
>
Elia E. Acevedo-Diaz
Elia E. Acevedo-Diaz
National Institutes of Health
Medicine
Antidepressant
Ketamine
Pharmaceutical industry
Clinical trial
3
Papers
9
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic
2021
Innovations in clinical neuroscience
Robert E. Litman
Peter Sorantin
Elia E. Acevedo-Diaz
Show All
Source
Cite
Save
Citations (0)
Reply to: "Letter to the Editor: Are ketamine-induced subjective bodily experiences associated with antidepressant effects? A sensation of floating and a sensation of Lightnessare not the same - A comment on Acevedo-Diaz et al." (Jpsychiatrres-D-21-00121).
2021
Journal of Psychiatric Research
Elia E. Acevedo-Diaz
Maximillian Greenwald
Grace W. Cavanaugh
Dede Greenstein
Christoph Kraus
Bashkim Kadriu
Carlos A. Zarate
Lawrence Park
Show All
Source
Cite
Save
Citations (0)
Can ‘Floating’ Predict Treatment Response to Ketamine? Data from Three Randomized Trials of Individuals with Treatment-Resistant Depression
2020
Journal of Psychiatric Research
Elia E. Acevedo-Diaz
Grace W. Cavanaugh
Dede Greenstein
Christoph Kraus
Bashkim Kadriu
Lawrence T. Park
Carlos A. Zarate
Show All
Source
Cite
Save
Citations (9)
1